@article {1408,
	title = {Pretransplant cryptococcosis and outcome after liver transplantation},
	journal = {Liver Transpl},
	volume = {16},
	year = {2010},
	note = {Sifri, Costi D Sun, Hsin-Yun Cacciarelli, Thomas V Wispelwey, Brian Pruett, Timothy L Singh, Nina Case Reports United States Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society Liver Transpl. 2010 Apr;16(4):499-502.},
	month = {Apr},
	pages = {499 - 502},
	edition = {40276},
	abstract = {The posttransplant outcomes and optimal management of patients with end-stage liver disease who develop cryptococcosis prior to transplantation have not been defined. We discuss these issues in the context of successful liver transplantation and pretransplant cryptococcal disease. Our report suggests that liver transplantation may be cautiously considered under the umbrella of fluconazole therapy in patients with end-stage liver disease and pretransplant cryptococcosis, provided that disease control is achieved with adequate treatment before transplantation.},
	keywords = {Antifungal Agents / therapeutic use, Cryptococcosis / *complications, Fibrosis / *complications / therapy, Fluconazole / therapeutic use, Humans, Immunosuppressive Agents / therapeutic use, Liver Failure / *complications / *therapy, Liver Transplantation / *methods, Male, Middle Aged, Preoperative Period, Time Factors, Treatment Outcome},
	issn = {1527-6473 (Electronic) 1527-6465 (Linking)},
	doi = {10.1002/lt.22024},
	author = {Sifri,C. D. and Sun,H. Y. and Cacciarelli,T. V. and Wispelwey,B. and Pruett,T. L. and Singh,N.}
}
